AIF1 and obesity disorder: Still, plausibility is supported by the fact that AIF1 is an adipokine previously described as being correlated with the waist-to-hip ratio (r = 0.23) and not BMI [25] and is associated with adverse metabolic phenotypes in women with obesity [33].